Can subtenon methylprednisolone acetate be a choice for the acute non-arteritic ischemic optic neuropathy treatment?

MLA

Ulusoy, Mahmut Oğuz, et al. “Can Subtenon Methylprednisolone Acetate Be a Choice for the Acute Non-Arteritic Ischemic Optic Neuropathy Treatment?” Romanian Journal of Ophthalmology, vol. 60, no. 4, Oct. 2016, pp. 275–78. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=29450362&authtype=sso&custid=ns315887.

APA

Ulusoy, M. O., Kıvanç, S. A., & Atakan, M. (2016). Can subtenon methylprednisolone acetate be a choice for the acute non-arteritic ischemic optic neuropathy treatment? Romanian Journal of Ophthalmology, 60(4), 275–278.

Chicago

Ulusoy, Mahmut Oğuz, Sertaç Argun Kıvanç, and Mehmet Atakan. 2016. “Can Subtenon Methylprednisolone Acetate Be a Choice for the Acute Non-Arteritic Ischemic Optic Neuropathy Treatment?” Romanian Journal of Ophthalmology 60 (4): 275–78. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=29450362&authtype=sso&custid=ns315887.